302 related articles for article (PubMed ID: 28280976)
1. Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma.
Kallini JR; Gabr A; Hickey R; Kulik L; Desai K; Yang Y; Gates VL; Riaz A; Salem R; Lewandowski RJ
Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1213-1222. PubMed ID: 28280976
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of primary and secondary hepatic malignancies associated with hepatopulmonary shunting.
Gaba RC; Zivin SP; Dikopf MS; Parvinian A; Casadaban LC; Lu Y; Bui JT
Radiology; 2014 May; 271(2):602-12. PubMed ID: 24533871
[TBL] [Abstract][Full Text] [Related]
3. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
[TBL] [Abstract][Full Text] [Related]
4. Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization.
Olorunsola OG; Kohi MP; Behr SC; Kolli PK; Taylor AG; Tong RT; LaBerge JM; Kerlan RK; Fidelman N
J Vasc Interv Radiol; 2015 Oct; 26(10):1472-8. PubMed ID: 26296737
[TBL] [Abstract][Full Text] [Related]
5. 90Y Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival.
Xing M; Lahti S; Kokabi N; Schuster DM; Camacho JC; Kim HS
Clin Nucl Med; 2016 Jan; 41(1):21-7. PubMed ID: 26222534
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic
Struycken L; Patel M; Kuo P; Hennemeyer C; Woodhead G; McGregor H
AJR Am J Roentgenol; 2022 Apr; 218(4):728-737. PubMed ID: 34704460
[No Abstract] [Full Text] [Related]
7. Comparison of Tc-99m MAA Planar Versus SPECT/CT Imaging for Lung Shunt Fraction Evaluation Prior to Y-90 Radioembolization: Are We Overestimating Lung Shunt Fraction?
Elsayed M; Cheng B; Xing M; Sethi I; Brandon D; Schuster DM; Bercu Z; Galt J; Barron B; Kokabi N
Cardiovasc Intervent Radiol; 2021 Feb; 44(2):254-260. PubMed ID: 33000319
[TBL] [Abstract][Full Text] [Related]
8. Is a Technetium-99m Macroaggregated Albumin Scan Essential in the Workup for Selective Internal Radiation Therapy with Yttrium-90? An Analysis of 532 Patients.
Sancho L; Rodriguez-Fraile M; Bilbao JI; Beorlegui Arteta C; Iñarrairaegui M; Moran V; Sangro B
J Vasc Interv Radiol; 2017 Nov; 28(11):1536-1542. PubMed ID: 28916345
[TBL] [Abstract][Full Text] [Related]
9. Tc-99m-MAA lung shunt fraction before Y-90 radioembolization is low among patients with non-hepatocellular carcinoma malignancies.
Elsayed M; Martin JG; Dabrowiecki A; Goldman DT; Faraj R; McMahon JT; Kokabi N; Duszak R; Newsome J; Bercu ZL
Nucl Med Commun; 2019 Nov; 40(11):1154-1157. PubMed ID: 31568192
[TBL] [Abstract][Full Text] [Related]
10. Association of dysmorphic intratumoral vessel with high lung shunt fraction in patients with hepatocellular carcinoma.
Choi TW; Joo I; Kim HC
Sci Rep; 2022 Aug; 12(1):14248. PubMed ID: 35989374
[TBL] [Abstract][Full Text] [Related]
11. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
[TBL] [Abstract][Full Text] [Related]
12. Hepatopulmonary shunting in patients with primary and secondary liver tumors scheduled for radioembolization.
Powerski MJ; Erxleben C; Scheurig-Münkler C; Geisel D; Heimann U; Hamm B; Gebauer B
Eur J Radiol; 2015 Feb; 84(2):201-7. PubMed ID: 25483014
[TBL] [Abstract][Full Text] [Related]
13. Miscalculated Lung Shunt Fraction for Planning of Hepatic Radioembolization.
Caskey JS; Kay MD; McMillan NA; Kuo PH; Woodhead GJ
J Nucl Med Technol; 2020 Jun; 48(2):184-186. PubMed ID: 31811062
[No Abstract] [Full Text] [Related]
14. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.
Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A
J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346
[TBL] [Abstract][Full Text] [Related]
15. Streamlining radioembolization in UNOS T1/T2 hepatocellular carcinoma by eliminating lung shunt estimation.
Gabr A; Ranganathan S; Mouli SK; Riaz A; Gates VL; Kulik L; Ganger D; Maddur H; Moore C; Hohlastos E; Katariya N; Caicedo JC; Kalyan A; Lewandowski RJ; Salem R
J Hepatol; 2020 Jun; 72(6):1151-1158. PubMed ID: 32145255
[TBL] [Abstract][Full Text] [Related]
16. Calculation of lung mean dose and quantification of error for
Lopez B; Mahvash A; Lam MGEH; Kappadath SC
Med Phys; 2019 Sep; 46(9):3929-3940. PubMed ID: 31063600
[TBL] [Abstract][Full Text] [Related]
17. Hepatopulmonary shunting on Tc99m-MAA liver mapping: correlation with dynamic cross-sectional imaging and description of different shunting patterns.
Bermo M; Matesan MC; Itani M; Behnia F; Vesselle HJ
Abdom Radiol (NY); 2018 Nov; 43(11):3001-3008. PubMed ID: 29632990
[TBL] [Abstract][Full Text] [Related]
18. Intraarterial Hepatic SPECT/CT Imaging Using 99mTc-Macroaggregated Albumin in Preparation for Radioembolization.
Gates VL; Singh N; Lewandowski RJ; Spies S; Salem R
J Nucl Med; 2015 Aug; 56(8):1157-62. PubMed ID: 26089551
[TBL] [Abstract][Full Text] [Related]
19. Organ-level internal dosimetry for intra-hepatic-arterial administration of
Kappadath SC; Lopez BP
Med Phys; 2022 Aug; 49(8):5504-5512. PubMed ID: 35612924
[TBL] [Abstract][Full Text] [Related]
20. Characterization of extrahepatic distribution of Tc-99m macroaggregated albumin in hepatic perfusion imaging studies prior to yttrium-90 microsphere therapy.
Jiang M; Nowakowski FS; Wang J; Heiba S; Zhang Z; Weintraub J; Kim E; Machac J
Cancer Biother Radiopharm; 2011 Aug; 26(4):511-8. PubMed ID: 21790309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
